Haiyan Cai
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Ubiquitin and proteasome pathways 8
- Peroxisome Proliferator-Activated Receptors 5
- Histone Deacetylase Inhibitors Research 4
- Protein Degradation and Inhibitors 3
- Oncology 7
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Aiwu Zhou (10 shared papers)Ting Xu (5 shared papers)Fei Zhang (4 shared papers)Hudie Wei (3 shared papers)Jiawei Wu (3 shared papers)Yugang Wang (2 shared papers)Pilin Wang (2 shared papers)Xiaoyong Jiang (2 shared papers)
- Journals
- Acta Pharmacologica Sinica (3 papers)Oncotarget (3 papers)European Journal of Medicinal Chemistry (2 papers)Cell Discovery (2 papers)Archives of Biochemistry and Biophysics (2 papers)
- Partner nations
- ChinaThailandUnited Kingdom
In The Last Decade
Haiyan Cai
32 papers receiving 674 citations
Peers
Comparison fields: 5 of 81
- Oncology 270
- Radiology, Nuclear Medicine and Imaging 171
- Immunology 154
- Molecular Biology 408
- Cancer Research 46
Countries citing papers authored by Haiyan Cai
This map shows the geographic impact of Haiyan Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiyan Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiyan Cai more than expected).
Fields of papers citing papers by Haiyan Cai
This network shows the impact of papers produced by Haiyan Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiyan Cai. The network helps show where Haiyan Cai may publish in the future.
Co-authors
The 25 scholars most cited alongside Haiyan Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 167 | |
| 2 | 2017 | 61 | |
| 3 | 2017 | 55 | |
| 4 | 2016 | 46 | |
| 5 | 2017 | 40 | |
| 6 | 2023 | 33 | |
| 7 | 2019 | 31 | |
| 8 | 2010 | 30 | |
| 9 | 2014 | 29 | |
| 10 | 2013 | 27 | |
| 11 | 2019 | 26 | |
| 12 | 2018 | 20 | |
| 13 | 2012 | 17 | |
| 14 | 2020 | 13 | |
| 15 | 2018 | 13 | |
| 16 | 2021 | 12 | |
| 17 | 2016 | 9 | |
| 18 | 2020 | 9 | |
| 19 | 2023 | 8 | |
| 20 | 2017 | 7 |
About Haiyan Cai
Haiyan Cai is a scholar working on Molecular Biology, Oncology, Immunology, Cellular and Molecular Neuroscience and Hematology, having authored 35 papers that have together received 687 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (8 papers), Peroxisome Proliferator-Activated Receptors (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Protein Degradation and Inhibitors (3 papers), Immunotherapy and Immune Responses (3 papers), Neuropeptides and Animal Physiology (3 papers) and Genetics and Neurodevelopmental Disorders (3 papers). The work is most often cited by research in Oncology (270 citations), Radiology, Nuclear Medicine and Imaging (171 citations), Immunology (154 citations), Molecular Biology (408 citations) and Cancer Research (46 citations). Haiyan Cai has collaborated with scholars based in China, Thailand and United Kingdom. Frequent co-authors include Aiwu Zhou, Ting Xu, Fei Zhang, Hudie Wei, Jiawei Wu, Yugang Wang, Pilin Wang, Xiaoyong Jiang, Xiaoxiao Wang and Yu Bai. Their work appears in journals such as Acta Pharmacologica Sinica, Oncotarget, European Journal of Medicinal Chemistry, Cell Discovery and Archives of Biochemistry and Biophysics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.